Check Cap Ltd
Veridion Score
Composite trend over time
Why is MBAI moving today?
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for MBAI.
MBAI insider activity
Check Cap Ltd
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for MBAI.
MBAI contract awards, year to date.
Public federal awards linked to this ticker.
MBAI lobbying filings, year to date.
Registered lobbying filings matched to Check Cap Ltd.